Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in previously treated Non Small Cell Lung Cancer (NSCLC)

Objective: The main aim of the study was to evaluate the efficacy and safety profile of Nivolumab, an immune-checkpoint-inhibitor antibody, in advanced, previously treated, Non-Small Cell Lung Cancer (NSCLC) patients, in a real world setting. Methods: We performed a retrospective, multicentre data a...

Full description

Bibliographic Details
Main Author: Figueiredo, A. (author)
Other Authors: Almeida, M.A. (author), Almodovar, M.T. (author), Alves, P. (author), A, Araujo (author), Araújo, D. (author), Barata, F. (author), Barradas, L. (author), Barroso, A. (author), Brito, U. (author), Camacho, E. (author), Canário, D. (author), Cardoso, T. (author), Chaves, A. (author), Costa, L. (author), Cunha, J. (author), Duarte, J. (author), Estevinho, F. (author), Felizardo, M. (author), Fernandes, J.P. (author), Ferreira, L. (author), Fidalgo, Paula (author), Freitas, C. (author), Garrido, P. (author), Gil, N. (author), Hasmucrai, D. (author), Jesus, E. (author), Lopes, J.A. (author), de Macedo, J.E. (author), Meleiro, A. (author), Neveda, R. (author), Nogueira, F. (author), Pantorotto, M. (author), Parente, B. (author), Pego, A. (author), Rocha, M. (author), Roque, J. (author), Santos, C. (author), Saraiva, J. (author), Silva, E. (author), Silva, S. (author), Simões, S. (author), Soares, M. (author), Teixeira, E. (author), Timóteo, T. (author), Hespanhol, V. (author)
Format: article
Language:eng
Published: 2022
Online Access:http://hdl.handle.net/10400.16/2698
Country:Portugal
Oai:oai:repositorio.chporto.pt:10400.16/2698

Internet

http://hdl.handle.net/10400.16/2698

Similar Items